loading

Verve Therapeutics Inc Stock (VERV) Forecast

The Verve Therapeutics Inc (VERV) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.94, representing a +182.29% increase from the current price of $4.23. The highest analyst price target is $11.35, and the lowest is $12.53.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VERV Price Target
Average 6.4609 (+52.74% Upside)
loading

Is Verve Therapeutics Inc (VERV) A Buy Now?

Oscillators
Name Value Action
RSI(14) 40.78 Neutral
STOCH(9,6) 14.37 Buy
STOCHRSI(14) 5.684 Buy
MACD(12,26) -0.116 Sell
ADX(14) 22.29 Neutral
William %R -91.22 Buy
CCI(14) -65.44 Neutral
Buy: 3 Sell: 1 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
5.00
Sell
4.7478
Sell
MA20
4.9245
Sell
4.8471
Sell
MA50
5.1414
Sell
5.2017
Sell
MA100
5.9656
Sell
5.609
Sell
MA200
5.7939
Sell
6.3752
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, VERV could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on VERV, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 40.78 indicates that VERV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 14.37 indicates that VERV is oversold. This indicates that VERV price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 5.684 indicates that VERV is oversold. This suggests that VERV price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 22.29 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -65.44 indicates that VERV is still oversold but not to an extreme extent.

Long-term VERV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Verve Therapeutics Inc financial reports and earnings history, Verve Therapeutics Inc (VERV) stock could reach $16.56 by 2030, $265.60 by 2040 and $388.34 by 2050. See the projected annual prices until 2050 of the Verve Therapeutics Inc stock below:

  • Verve Therapeutics Inc (VERV) is expected to reach an average price of $98.15 in 2035, with a high prediction of $107.52 and a low estimate of $108.60. This indicates an $2,220% rise from the last recorded price of $4.23.
  • Verve Therapeutics Inc (VERV) stock is projected to chart a bullish course in 2040, with an average price target of $274.43, representing an $6,388% surge from its current level. The forecast ranges from a conservative $268.93 to a sky-high $265.60.
  • Our analysts predict Verve Therapeutics Inc (VERV) to jump 3,545% by 2045, soaring from $156.21 to an average price of $154.16, potentially reaching $161.16. While $156.21 is the low estimate, the potential upside is significant.
  • Verve Therapeutics Inc (VERV) stock is expected to climb by 2050, reaching an average of $384.43, a $8,988% jump from its current level. However, a wide range of estimates exists, with high and low targets of $388.34 and $384.55, respectively, highlighting the market's uncertainty.

Verve Therapeutics Inc Stock (VERV) Year by Year Forecast

Verve Therapeutics Inc Stock (VERV) Price Forecast for 2025

Verve Therapeutics Inc Stock (VERV) is expected to reach an average price of $14.97 in 2025, with a high prediction of $29.15 and a low estimate of $0.802. This indicates an +253.99% rise from the last recorded price of $4.23.
Month Average Low High Change from today's price
June, 2025 $2.9418 $12.53 $11.35 -30.45%
July, 2025 $1.8095 $0.802 $5.1047 -57.22%
August, 2025 $2.1674 $2.1839 $5.3378 -48.76%
September, 2025 $3.3057 $3.1557 $6.3057 -21.85%
October, 2025 $9.5729 $3.706 $9.7812 +126.31%
November, 2025 $13.32 $10.93 $12.12 +214.89%
December, 2025 $7.5185 $8.8385 $11.63 +77.74%

Verve Therapeutics Inc Stock (VERV) Price Forecast for 2026

The predicted value for Verve Therapeutics Inc (VERV) in 2026 is set at an average of $5.8435. Estimates vary from a peak of $11.38 to a trough of $0.3046, indicating an +38.14% surge from the present price of $4.23.
Month Average Low High Change from today's price
January, 2026 $7.5654 $8.1202 $6.5454 +78.85%
February, 2026 $10.31 $9.3688 $8.6888 +143.79%
March, 2026 $12.53 $10.77 $11.38 +196.20%
April, 2026 $6.9978 $9.0478 $9.9209 +65.43%
May, 2026 $6.9847 $8.1447 $6.983 +65.12%
June, 2026 $3.2316 $4.1199 $4.5864 -23.60%
July, 2026 $0.0998 $0.5502 $2.0133 -97.64%
August, 2026 $6.0771 $1.7119 $4.5171 +43.67%
September, 2026 $5.4358 $5.5206 $5.3489 +28.51%
October, 2026 $6.9727 $5.281 $4.3427 +64.84%
November, 2026 $0.7204 $0.3046 $5.9044 -82.97%
December, 2026 $0.5982 $2.0282 $1.9065 -85.86%

Verve Therapeutics Inc Stock (VERV) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Verve Therapeutics Inc (VERV) is $34.18, with a high forecast of $68.33 and a low forecast of $0.0234. This indicates an +707.97% increase from the last price of $4.23.
Month Average Low High Change from today's price
January, 2027 $1.2049 $0.4649 $2.9066 -71.52%
February, 2027 $0.022 $0.072 $2.5232 -99.48%
March, 2027 $7.7993 $0.0438 $10.09 +84.38%
April, 2027 $4.9924 $4.6924 $8.3976 +18.02%
May, 2027 $0.0645 $0.0234 $5.9707 -98.48%
June, 2027 $43.65 $0.0904 $47.74 +932.00%
July, 2027 $51.56 $43.51 $39.19 +1,119%
August, 2027 $64.97 $64.06 $59.71 +1,436%
September, 2027 $57.44 $58.39 $61.37 +1,258%
October, 2027 $71.22 $64.92 $68.33 +1,584%
November, 2027 $63.75 $64.56 $65.55 +1,407%
December, 2027 $68.61 $68.07 $67.66 +1,522%

Verve Therapeutics Inc Stock (VERV) Price Forecast for 2028

In 2028, Verve Therapeutics Inc (VERV) is projected to reach an average price of $51.85, with a high projection of $72.45 and a low estimate of $31.24. This indicates an +1,126% rise from the last price of $4.23.
Month Average Low High Change from today's price
January, 2028 $64.13 $69.17 $66.65 +1,416%
February, 2028 $67.36 $64.25 $65.15 +1,492%
March, 2028 $68.83 $68.04 $67.45 +1,527%
April, 2028 $72.88 $72.19 $72.45 +1,623%
May, 2028 $70.82 $70.04 $70.70 +1,574%
June, 2028 $65.25 $65.52 $69.93 +1,443%
July, 2028 $53.72 $54.13 $58.63 +1,170%
August, 2028 $36.79 $38.80 $50.20 +769.84%
September, 2028 $37.52 $37.75 $35.64 +786.95%
October, 2028 $38.06 $38.80 $36.82 +799.80%
November, 2028 $43.47 $31.24 $40.01 +927.63%
December, 2028 $42.68 $43.42 $42.90 +909.05%

Verve Therapeutics Inc Stock (VERV) Price Forecast for 2029

The 2029 price forecast for Verve Therapeutics Inc Stock (VERV) is $32.30 on average, with a high prediction of $43.65 and a low estimate of $20.94. This represents an +663.48% increase from the previous price of $4.23.
Month Average Low High Change from today's price
January, 2029 $38.21 $41.49 $43.65 +803.31%
February, 2029 $35.31 $37.74 $36.48 +734.84%
March, 2029 $37.06 $37.40 $36.72 +776.07%
April, 2029 $39.09 $37.85 $36.45 +824.15%
May, 2029 $34.40 $35.01 $37.82 +713.21%
June, 2029 $31.79 $32.21 $32.76 +651.60%
July, 2029 $25.34 $28.28 $30.56 +498.97%
August, 2029 $21.23 $22.49 $24.40 +401.98%
September, 2029 $21.53 $20.94 $20.60 +408.92%
October, 2029 $23.71 $24.00 $24.15 +460.63%
November, 2029 $21.34 $22.39 $22.11 +404.46%
December, 2029 $19.19 $21.85 $21.84 +353.72%

Verve Therapeutics Inc Stock (VERV) Price Forecast for 2030

Verve Therapeutics Inc Stock (VERV) is expected to reach an average price of $60.97 in 2030, with a high forecast of $120.23 and a low forecast of $1.7148. This signifies an +1,341% surge from the last price of $4.23.
Month Average Low High Change from today's price
January, 2030 $16.77 $15.28 $16.56 +296.44%
February, 2030 $11.21 $12.10 $15.61 +165.09%
March, 2030 $11.02 $10.89 $10.26 +160.45%
April, 2030 $8.011 $10.10 $9.6675 +89.38%
May, 2030 $2.2682 $1.7148 $6.1844 -46.38%
June, 2030 $6.162 $2.6686 $1.6937 +45.67%
July, 2030 $5.6691 $5.6593 $5.6789 +34.02%
August, 2030 $97.68 $99.87 $105.05 +2,209%
September, 2030 $118.30 $101.95 $114.77 +2,697%
October, 2030 $114.23 $118.95 $115.50 +2,601%
November, 2030 $123.50 $111.24 $114.58 +2,820%
December, 2030 $113.56 $121.37 $120.23 +2,585%
$65.08
price down icon 0.84%
$19.36
price down icon 0.31%
$33.15
price up icon 0.15%
$23.96
price down icon 2.80%
$92.77
price down icon 2.12%
biotechnology ONC
$231.99
price down icon 1.67%
Cap:     |  Volume (24h):